Onconetix
ONCO
6 hedge funds and large institutions have $304K invested in Onconetix in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 2 closing their positions.
607% more capital invested
Capital invested by funds: $43K → $304K (+$261K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
20% more funds holding
Funds holding: 5 → 6 (+1)
0.09% more ownership
Funds ownership: 0.03% → 0.13% (+0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$208K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$52.7K |
| 3 |
PCWA
Pacific Capital Wealth Advisors
Corona,
California
|
+$43.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.04K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$27.7K |
| 2 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$134 |
ONCO Hedge Fund Activity: Q3 2025 in Review
6 of the 7,637 institutional investors tracked by Wall St. Rank reported a position in Onconetix (ONCO) for Q3 2025, worth a combined $304K — up 607% from $43K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new ONCO positions and 2 closed out — a net gain of 1 holder — while 3 added to existing stakes and 0 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $208K. The largest seller was Morgan Stanley, exiting entirely with an estimated $27.7K sold.
- 6 institutional investors held Onconetix (ONCO) as of Q3 2025, up from 5 in Q2 2025.
- Funds reported $304K of Onconetix stock for Q3 2025, up 607% quarter-over-quarter.
- 3 funds opened new Onconetix positions in Q3 2025 and 2 closed out, a net change of +1 holder.
- The largest Onconetix buyer in Q3 2025 was DRW Securities, an estimated $208K added.
- The largest Onconetix seller in Q3 2025 was Morgan Stanley, an estimated $27.7K sold.
Based on aggregated 13F filings for Q3 2025.